文献速递炎症性肠病

局限性溃疡性结肠炎的分子特征揭示新生物学及疾病扩展预测因子

Molecular Characterization of Limited Ulcerative Colitis Reveals Novel Biology and Predictors of Disease Extension.
PubMed 文献 · Gastroenterology · 2021-09-02

本研究对局限性溃疡性结肠炎患者的内镜活检组织进行RNA测序,比较炎症最远端与近端未受累肠段基因表达。发现炎症部位基因表达在近端未受累组织呈 abrupt 或 gradual 过渡,gradual 过渡基因涉及炎症、血管生成等通路,且部分基因可预测疾病扩展并响应生物制剂,PARP14 为潜在关键驱动基因。

要点

  • 局限性UC内镜下炎症最远端基因表达与健康对照差异显著,近端未受累组织基因表达可呈 abrupt 或 gradual 过渡。
  • Gradual 过渡基因涉及炎症、血管生成、葡萄糖醛酸化和同源域通路,支持内镜下分界外存在疾病。
  • 炎症部位部分基因预测疾病扩展优于临床特征,且响应生物制剂,PARP14 为预测关键驱动基因。

核心结论

  • 局限性UC的分子特征揭示疾病扩展预测因子及潜在治疗靶点,PARP14 为预测扩展的关键驱动基因。

研究设计与样本

  • 对内镜和组织学确诊的局限性UC患者活检标本进行RNA测序分析,标本取自内镜下炎症近端界限及更近端未受累肠段,部分患者 later 出现疾病扩展。

主要发现

  • 与健康对照相比,每位患者最远受累炎症活检标本中鉴定出差异表达基因。
  • 这些基因在更近端活检标本中的表达 abrupt 或 gradual 地回归对照水平,gradual 模式支持内镜下分界外存在疾病。
  • Gradual 过渡基因与炎症、血管生成、葡萄糖醛酸化及同源域通路相关。
  • 炎症活检标本中部分基因预测疾病扩展优于临床特征,且响应生物制剂。
  • 网络分析显示干扰素信号在UC炎症中起关键作用,PARP14 为预测扩展的关键驱动基因。

临床怎么用

  • 分子预测因子可用于局限性UC的疾病预后评估,PARP14 等潜在靶点可能指导治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Disease extent varies in ulcerative colitis (UC) from proctitis to left-sided colitis to pancolitis and is a major prognostic factor. When the extent of UC is limited there is often a sharp demarcation between macroscopically involved and uninvolved areas and what defines this or subsequent extension is unknown. We characterized the demarcation site molecularly and determined genes associated with subsequent disease extension. METHODS: We performed RNA sequence analysis of biopsy specimens from UC patients with endoscopically and histologically confirmed limited disease, of which a subset later extended. Biopsy specimens were obtained from the endoscopically inflamed upper (proximal) limit of disease, immediately adjacent to the uninvolved colon, as well as at more proximal, endoscopically uninflamed colonic segments. RESULTS: Differentially expressed genes were identified in the endoscopically inflamed biopsy specimens taken at each patient's most proximal diseased site relative to healthy controls. Expression of these genes in the more proximal biopsy specimens transitioned back to control levels abruptly or gradually, the latter pattern supporting the concept that disease exists beyond the endoscopic disease demarcation site. The gradually transitioning genes were associated with inflammation, angiogenesis, glucuronidation, and homeodomain pathways. A subset of these genes in inflamed biopsy specimens was found to predict disease extension better than clinical features and were responsive to biologic therapies. Network analysis revealed critical roles for interferon signaling in UC inflammation and poly(ADP-ribose) polymerase 14 (PARP14) was a predicted key driver gene of extension. Higher PARP14 protein levels were found in inflamed biopsy specimens of patients with limited UC that subsequently extended. CONCLUSION: Molecular predictors of disease extension reveal novel strategies for disease prognostication and potential therapeutic targeting.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Argmann C, Tokuyama M, Ungaro RC, et al. Molecular Characterization of Limited Ulcerative Colitis Reveals Novel Biology and Predictors of Disease Extension. Gastroenterology. 2021. PMID: 34480882. doi:10.1053/j.gastro.2021.08.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。